This site is intended for healthcare professionals
News

EU recommends change to marketing authorisation for Epclusa in chronic hepatitis C virus infection.- Gilead Sciences

Read time: 1 mins
Last updated:29th Jun 2020
Published:28th Jun 2020
Condition: Hepatitis C
Type: drug
Register free for full access to medthority.com